EXHIBIT 99.1


                                  [XTRANA LOGO]


FOR IMMEDIATE RELEASE

                         XTRANA ANNOUNCES TERMINATION OF
                  MERGER DISCUSSIONS WITH ADUROMED CORPORATION

September 13, 2004 -- XTRANA,  Inc.  (OTCBB:  XTRN)  announced today that it has
terminated  the  previously  announced  negotiations  with Aduromed  Corporation
regarding a potential  business  combination  between the two companies.  Xtrana
determined to end  negotiations  and terminate the non-binding  letter of intent
with Aduromed as result of Xtrana's due diligence  investigation of Aduromed and
its business.

James  Chamberlain,  Xtrana's  Interim CEO  commented,  "Despite  termination of
discussions  with Aduromed  Corporation,  we will continue  exploring  potential
transactions for merging or otherwise joining together with an existing business
that could create long-term  stockholder value while simultaneously  examining a
possible  liquidation  of Xtrana and  distribution  of its  remaining  assets to
stockholders."

The Xtrana  Board of  Directors  continues  to believe  that  Xtrana can attract
interest from other businesses that might benefit from access TO Xtrana's funds,
as well as Xtrana's status as a public company with a clean  reporting  history.
It is the  intention  of the Xtrana  Board of  Directors  to continue to spend a
limited period of time exploring  opportunities to find a merger candidate,  and
if it is unable to conclude a  transaction  that it believes  would provide long
term stockholder  value, to propose that the stockholders  approve a liquidation
of the company.


This Press Release contains forward-looking  statements (identified by the words
"estimate,"  "anticipate," "expect," "believe," and similar expressions),  which
are based upon management's  current  expectations and speak only as of the date
made. These forward-looking  statements are subject to risks,  uncertainties and
factors that could cause actual  results to differ  materially  from the results
anticipated in the forward-looking  statements and include,  but are not limited
to, our  ability  to settle our  remaining  obligations,  our  ability to find a
merger  partner,  as well as other factors  discussed in our last Report on Form
10-KSB.

CONTACT:          Dennis Lineberry
                  Vice President, Finance
                  Xtrana, Inc.
                  (303) 466-4424